FDA recall D-0598-2026 · initiated May 22, 2026
May cause temporary or medically reversible harm; low probability of serious harm.
Labeling: Not Elsewhere Classified. This recall has been initiated in response to the denial by FDA of marketing the product under the proprietary name Xyvona